Skip to content
healthcare.dev

Mucus Relief DM MAXIMUM STRENGTH

NDC 21130-989, Guaifenesin and Dextromethorphan HBr, tablet, extended release, from Better Living Brands LLC.

Product NDC
21130-989
Status
Listed
Labeler
Better Living Brands LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA206941
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/21130-989 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN1200 mg/1
  • DEXTROMETHORPHAN HYDROBROMIDE60 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]

Package NDCNDC-11Package
21130-989-03211300989034 BLISTER PACK in 1 CARTON (21130-989-03) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
21130-989-65211300989652 BLISTER PACK in 1 CARTON (21130-989-65) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 21130-989 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/21130-989 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 21130-989. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.